How FARA and Horizon Pharma Partnered to Improve Clinical Development

Patients as Partners Day 2 Session

How FARA and Horizon Pharma Partnered to Improve Clinical Development and Trial Design-Case Study
This session will feature how the Friedreich’s Ataxia Research Foundation collaborated with Horizon Pharma on aspects of clinical development and trial design to better understand patients living with the disease and how to better develop medicine to help manage their disease. Key areas of discussion include how they collaborated on the following:

• Focus groups to better understand drug administration • Clinical trial design to ensure feasibility and efficiency • Recruiting patients for clinical trials
• Open discussion at FDA meetings

Kyle Bryant

Director of the Bicycle Ride Fundraiser, rideAtaxia for the Friedreich’s Ataxia Research Alliance (FARA) 

Robert Metz

SVP, Global Business Operations and External Affairs, Horizon Pharma